Jazz Pharmaceuticals (JAZZ) Profit After Tax (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Profit After Tax of $293.1 million for Q1 2026, up 416.86% year-over-year from $56.7 million in Q1 2025, and up 44.06% quarter-over-quarter from $203.5 million in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Profit After Tax (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Profit After Tax history runs 17 years deep, the most recent figure standing at $293.1 million for Q1 2026.
- In Q1 2026, Profit After Tax rose 416.86% year-over-year to $293.1 million; the TTM figure through Mar 2026 stood at $29.5 million (down 93.88% YoY), while the FY2025 annual figure was -$356.1 million, down 163.58% from the prior year.
- Profit After Tax for Q1 2026 stood at $293.1 million, up from $203.5 million in the prior quarter.
- The five-year high for Profit After Tax was $293.1 million in Q1 2026, with the low at -$718.5 million in Q2 2025.
- The 5-year median for Profit After Tax is $113.4 million (2023), against an average of $11.6 million.
- The sharpest annual moves came in 2022 and 2023: Profit After Tax tumbled 580.95% in 2022, then soared 8720.83% in 2023.
- Jazz Pharmaceuticals' Profit After Tax stood at -$240.7 million in 2022, then surged by 139.11% to $94.2 million in 2023, then surged by 102.98% to $191.1 million in 2024, then climbed by 6.45% to $203.5 million in 2025, then surged by 44.06% to $293.1 million in 2026.
- Business Quant data shows JAZZ's Profit After Tax at $293.1 million in Q1 2026, $203.5 million in Q4 2025, and $251.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | 192.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 192.80 Mn |
| Mar 31, 2026 | 293.10 Mn |
| Dec 31, 2025 | 203.45 Mn |
| Sep 30, 2025 | 251.41 Mn |
| Jun 30, 2025 | -718.47 Mn |
| Mar 31, 2025 | -92.50 Mn |
| Dec 31, 2024 | 191.12 Mn |
| Sep 30, 2024 | 215.06 Mn |
| Jun 30, 2024 | 168.57 Mn |
| Mar 31, 2024 | -40.25 Mn |
| Dec 31, 2023 | 94.15 Mn |
| Sep 30, 2023 | 146.82 Mn |
| Jun 30, 2023 | 113.41 Mn |
| Mar 31, 2023 | 145.28 Mn |
| Dec 31, 2022 | -240.72 Mn |
| Sep 30, 2022 | -19.65 Mn |
| Jun 30, 2022 | -515.31 Mn |
| Mar 31, 2022 | 1.65 Mn |
| Dec 31, 2021 | -35.35 Mn |
| Sep 30, 2021 | -52.83 Mn |